{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:22:46Z","timestamp":1784769766492,"version":"3.55.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T00:00:00Z","timestamp":1435017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0131405","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T17:59:25Z","timestamp":1435082365000},"page":"e0131405","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs"],"prefix":"10.1371","volume":"10","author":[{"given":"Karolin","family":"Hijazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Cuppone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieron","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Stincarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Ekeruche-Makinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"De Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina L.","family":"Hold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Shattock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Iannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJMoa0707957","article-title":"Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission","volume":"359","author":"L Van Damme","year":"2008","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","article-title":"Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial","volume":"360","author":"L Van Damme","year":"2002","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1371\/journal.pone.0001312","article-title":"SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana","volume":"2","author":"L Peterson","year":"2007","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial","volume":"372","author":"S Skoler-Karpoff","year":"2008","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","article-title":"PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial","volume":"376","author":"S McCormack","year":"2010","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Q Abdool Karim","year":"2010","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"JM Marrazzo","year":"2015","journal-title":"N Engl J Med"},{"key":"ref8","unstructured":"Rees H, Delany-Moretlwe S, Baron D, Lombard C, Gray G, Myer L, et al. FACTS 001 Phase III Trial of Pericoital Tenofovir 1% Gel for HIV Prevention in Women. Conference on Retroviruses and Opportunistic Infections (CROI). February 23\u201326, 2015 | Seattle, Washington: Abstract 26LB."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2796.2011.02454.x","article-title":"Specific microbicides in the prevention of HIV infection","volume":"270","author":"CG Kelly","year":"2011","journal-title":"J Intern Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.immuni.2007.01.007","article-title":"Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1","volume":"26","author":"F Hladik","year":"2007","journal-title":"Immunity"},{"key":"ref11","article-title":"Expression and Localization of P-Glycoprotein, Multidrug Resistance Protein 4, and Breast Cancer Resistance Protein in the Female Lower Genital Tract of Human and Pigtailed Macaque","author":"T Zhou","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref12","article-title":"Expression of Transporters and Metabolizing Enzymes in the Female Lower Genital Tract: Implications for Microbicide Research","author":"T Zhou","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2004.11.005","article-title":"Cell entry and export of nucleoside analogues","volume":"107","author":"M Pastor-Anglada","year":"2005","journal-title":"Virus Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2009.10.001","article-title":"The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters","volume":"31","author":"O Kis","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkl474","article-title":"Modulation of human BCRP (ABCG2) activity by anti-HIV drugs","volume":"59","author":"J Weiss","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/dmd.106.012765","article-title":"Inhibition of MRP1\/ABCC1, MRP2\/ABCC2, and MRP3\/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors","volume":"35","author":"J Weiss","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00498250903509375","article-title":"Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1","volume":"40","author":"P Annaert","year":"2010","journal-title":"Xenobiotica"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.intimp.2013.05.003","article-title":"Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors","volume":"16","author":"M Tempestilli","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1095\/biolreprod57.4.847","article-title":"Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins","volume":"57","author":"RN Fichorova","year":"1997","journal-title":"Biol Reprod"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/jac\/dkq324","article-title":"Impact of drug transporters on cellular resistance towards saquinavir and darunavir","volume":"65","author":"SK Konig","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"J Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"TD Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1128\/AAC.00456-10","article-title":"In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides","volume":"54","author":"Y Gali","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"I Hubatsch","year":"2007","journal-title":"Nat Protoc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e77340","DOI":"10.1371\/journal.pone.0077340","article-title":"Global expression of molecular transporters in the human vaginal tract: implications for HIV chemoprophylaxis","volume":"8","author":"M Gunawardana","year":"2013","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1021\/mp5005004","article-title":"Vaginal expression of efflux transporters and the potential impact on the disposition of microbicides in vitro and in rabbits","volume":"11","author":"C Grammen","year":"2014","journal-title":"Mol Pharm"},{"key":"ref27","unstructured":"International Partnership for Microbicides. 2015. The Ring Study. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ipmglobal.org\/the-ring-study\" xlink:type=\"simple\">http:\/\/www.ipmglobal.org\/the-ring-study<\/ext-link>."},{"key":"ref28","unstructured":"Microbicides Trial Network. 2015. A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 3 Safety and Effectiveness Trial of a Vaginal Matrix Ring Containing Dapivirine for the Prevention of HIV-1 Infection in Women. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.mtnstopshiv.org\/studies\/3614\" xlink:type=\"simple\">http:\/\/www.mtnstopshiv.org\/studies\/3614<\/ext-link>."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1093\/jac\/dku160","article-title":"Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir","volume":"69","author":"DJ Murphy","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-4274(01)00306-X","article-title":"Up-regulation of transporters of the MRP family by drugs and toxins","volume":"120","author":"D Schrenk","year":"2001","journal-title":"Toxicol Lett"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2013.08.054","article-title":"Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents","volume":"439","author":"Y Hashiguchi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/jac\/dkm353","article-title":"Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes","volume":"60","author":"O Janneh","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/aid.2007.0022","article-title":"Comparison of ABC transporter modulation by atazanavir in lymphocytes and human brain endothelial cells: ABC transporters are involved in the atazanavir-limited passage across an in vitro human model of the blood-brain barrier","volume":"24","author":"L Bousquet","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/01.aids.0000194793.36175.40","article-title":"Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP","volume":"19","author":"O Janneh","year":"2005","journal-title":"AIDS"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1073\/pnas.120159197","article-title":"Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs","volume":"97","author":"J Wijnholds","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1128\/AAC.00251-06","article-title":"Mechanism of active renal tubular efflux of tenofovir","volume":"50","author":"AS Ray","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1248\/bpb.32.1588","article-title":"P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines","volume":"32","author":"H Fujimoto","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAD.0000000000000112","article-title":"Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta","volume":"28","author":"Z Neumanova","year":"2014","journal-title":"AIDS"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/QAD.0b013e32834b3629","article-title":"Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants","volume":"25","author":"C Herrera","year":"2011","journal-title":"AIDS"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1128\/AAC.06284-11","article-title":"Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model","volume":"56","author":"M Cost","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: function and regulation","volume":"62","author":"CD Klaassen","year":"2010","journal-title":"Pharmacol Rev"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.00671-07","article-title":"Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro","volume":"51","author":"L Tong","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1128\/AAC.00733-08","article-title":"Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation","volume":"53","author":"L Bousquet","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.1158\/1078-0432.CCR-05-1096","article-title":"Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia","volume":"11","author":"SL Plasschaert","year":"2005","journal-title":"Clin Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0131405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T15:20:41Z","timestamp":1540308041000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0131405"}},"subtitle":[],"editor":[{"given":"Roger","family":"Le Grand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,23]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0131405","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,23]]}}}